Drug intelligence / Profile preview

Jingfang Granules

Development stage
Phase 3
Lead developer
Lunan Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Jingfang Granules (JFG) is a traditional Chinese medicine prescription used primarily for treating skin diseases such as urticaria and influenza-like illnesses. It has demonstrated efficacy in improving glucose metabolism disturbances and inflammation in animal models of urticaria by modulating immune responses and inflammatory pathways. JFG acts by activating the LKB1/AMPK/SIRT1 signaling axis, which inhibits glycolysis/gluconeogenesis and the pentose phosphate pathway, thereby reducing inflammation. It also downregulates inflammatory cytokines (IgE, IL-1β, IL-6, IL-4, TNF-α, IL-17A) while increasing IFN-γ levels. Additionally, JFG has shown neuroprotective effects in intracerebral hemorrhage models by attenuating neuroinflammation and protecting the blood-brain barrier via activation of the PI3K/Akt signaling pathway. Clinically, it is used to relieve symptoms of common cold due to wind-cold including headache, bodily pain, nasal obstruction with watery discharge, cough with white sputum; it induces diaphoresis to expel wind and clear dampness.

Brand names
Jingfang Granule
Other names
JingFangJing Fang He Ji启达力
02

Targets

TLR4 (Toll-like receptor 4)NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)

Beyond the preview

Go deeper on Jingfang Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jingfang Granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call